[{"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":2261000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":2263000000.0,"RevenuesConverted_1_Q2_USD":10129000000.0,"RevenuesConverted_2_Q2_USD":20910000000.0,"CommonStockDividendsPerShareDeclared_2_Q2_USD":0.45,"CommonStockDividendsPerShareDeclared_1_Q2_USD":0.45,"Assets_0_Q2_USD":128076000000.0,"NetIncomeLossConverted_2_Q2_USD":-846000000.0,"StockholdersEquity_0_Q2_USD":49094000000.0,"EarningsPerShareDiluted_2_Q2_USD":-0.38,"EarningsPerShareDiluted_1_Q2_USD":-0.04,"NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":8163000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":2261000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":2263000000.0,"StockholdersEquityConverted_0_Q2_USD":49160000000.0,"NetIncomeLossConverted_1_Q2_USD":-85000000.0,"EarningsPerShareBasic_1_Q2_USD":-0.04,"EarningsPerShareBasic_2_Q2_USD":-0.38,"Ticker":"BMY","CIK":"14272","name":"BRISTOL MYERS SQUIBB CO","OfficialName":"Bristol-Myers Squibb Company Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"2","uom":"USD","footnote":"nan","Market Cap":"162365000000.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"SP500","filed":"20200806"}]